The IMID Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Latest episodes
Jul 5, 2021 • 16min
Discussing Rheumatology: 2021 EULAR Highlights
Prof Iain McInnes discusses the main highlights of EULAR 2021 and the key takeaway messages.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
Jun 23, 2021 • 11min
Rheumatology Author Professor Stanley Cohen: Radiographic Progression
Stanley Cohen, Clinical Professor in the Department of Internal Medicine and Co-Director of the Division of Rheumatology from the UT Southwestern Medical Center and Presbyterian Hospital, Dallas. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Cohen discusses radiographic progression in patients with RA treated with tofacitinib.
Jun 5, 2021 • 15min
Insights at EULAR 2021: Day 4 Highlights
Dr Elena Nikiphorou presents the Day 4 highlights of the key abstracts and posters presented at EULAR 2021.
Jun 4, 2021 • 32min
Insights at EULAR 2021: Day 3 Highlights
Professor Douglas Veale presents the Day 3 highlights of the key abstracts and posters presented at EULAR 2021.
Jun 3, 2021 • 19min
Insights at EULAR 2021: Day 2 Highlights
Dr Elena Nikiphorou presents the Day 2 highlights of the key abstracts and posters presented at EULAR 2021.
Jun 2, 2021 • 25min
Insights at EULAR 2021: Day 1 Highlights
Prof Veale presents the Day 1 highlights of the key abstracts and posters presented at EULAR 2021.
Jun 1, 2021 • 14min
Insights at EULAR 2021: Preview
A preview of the latest research at EULAR 2021.
Prof Edwards presents a preview of the upcoming EULAR 2021 congress, highlighting important abstracts and posters in cytokine signalling.
May 28, 2021 • 9min
Discussing Rheumatology: PsA and Radiographic Progression
Prof Iain McInnes discusses upadacitinib in PsA, and radiographic progression with tofacitinib.
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
May 13, 2021 • 29min
Rheumatology Author Professor Yoshiya Tanaka: Filgotinib
Yoshiya Tanaka, Professor and Chairman of the department of Internal Medicine at the University of Occupational and Environmental Health in Kitakyushu, Japan. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Tanaka discusses the safety and efficacy of filgotinib as a Novel JAK1-Preferential Inhibitor for the Treatment of RA.
Apr 28, 2021 • 32min
Rheumatology Author Dr Rishi Desai: VTE
Dr Rishi Desai, is an Assistant Professor of Medicine at Harvard Medical School and an Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Rishi Desai discusses Risk of venous thromboembolism associated with tofacitinib in patients with RA
